CBD is generally safe for dogs’ livers at typical doses, but it does put extra work on the liver and consistently causes a specific liver enzyme to rise in studies. In most dogs, this elevation stays within normal ranges and doesn’t cause clinical liver damage. However, the risk increases meaningfully when CBD is combined with other medications that also tax the liver.
What CBD Does to Your Dog’s Liver
Your dog’s liver is where CBD gets processed. The liver uses a family of enzymes called cytochrome P450 to break CBD down into an active form, which then gets converted into an inactive form and cleared from the body. This is the same enzyme system the liver uses to process many common medications, from anti-seizure drugs to pain relievers.
The issue isn’t that CBD poisons the liver. It’s that CBD ramps up production of these processing enzymes, and that increased activity shows up on blood work as elevated liver values. Think of it like running your car engine harder: the engine still works, but it’s under more load. In a 90-day safety study of healthy beagles given 5 mg of total cannabinoids per kilogram of body weight daily, ALP (alkaline phosphatase, a key liver enzyme vets check on routine blood panels) rose significantly compared to controls at 28, 56, and 90 days. But nearly all values stayed within normal laboratory ranges, and the changes were considered not clinically relevant by the researchers.
How Common Are Liver Enzyme Elevations?
ALP elevation is the most consistently reported liver-related effect of CBD in dogs. It shows up across multiple studies at various doses and durations. In one dose-escalation study of 20 dogs, 10% experienced ALP increases of roughly three to four times their baseline levels. In the 90-day beagle study, most dogs showed ALP increases that stayed within normal bounds, but one dog’s ALP climbed to 314 U/L on day 28 (the normal upper limit was 115 U/L) before gradually declining to 205 U/L by day 90.
ALT, another liver enzyme vets monitor, is less consistently affected. In the 90-day study, ALT values in treated dogs actually decreased from baseline in all CBD groups. This pattern suggests that the ALP elevation is more about increased enzyme activity from processing CBD than about actual liver cell damage, which would typically push both ALP and ALT upward together.
The Merck Veterinary Manual notes that these ALP elevations in dogs are suspected to be secondary to the enzyme induction process and are transient, meaning they tend to normalize after CBD is discontinued.
The Real Risk: Combining CBD With Other Medications
Where liver safety becomes a genuine concern is when your dog takes CBD alongside other drugs that use the same liver pathways. Because CBD increases the activity of processing enzymes, it can change how quickly or slowly other medications are metabolized, and the combined load on the liver compounds the effect.
A study looking at dogs with mobility problems found that dogs receiving both CBD and NSAIDs (common anti-inflammatory pain relievers) had significantly greater ALP increases than dogs on CBD alone. More concerning, ALT also rose in dogs on the combination, which wasn’t seen with either substance alone. That ALT elevation is a more worrying signal because it can indicate liver cells are under genuine stress. Similar patterns have been observed when CBD is combined with phenobarbital, a widely prescribed anti-seizure medication for dogs. Both phenobarbital and NSAIDs are independently associated with liver enzyme elevations, so adding CBD creates a compounding effect.
If your dog currently takes any prescription medication, this is the most important factor to discuss with your vet before starting CBD. The interaction potential is real and measurable.
What Dose Is Considered Safe?
The 90-day beagle study used 5 mg of total cannabinoids per kilogram of body weight per day and concluded this dose was well tolerated, with no clinically significant liver damage. Most clinical trials in dogs use doses in the 2 to 5 mg/kg range. At the other end of the spectrum, a single oral dose of 62 mg/kg (far above any therapeutic dose) caused diarrhea but not acute liver failure.
Some researchers have suggested that splitting the daily dose into twice-daily administration might reduce the impact on liver enzymes compared to giving the full amount at once, though this hasn’t been confirmed in controlled studies yet. What’s clear is that staying within studied dose ranges, rather than guessing or escalating on your own, matters for liver safety.
Signs of Liver Stress to Watch For
Most liver enzyme changes from CBD won’t produce visible symptoms in your dog. They only show up on blood work. That’s why veterinary professionals recommend periodic liver panels for dogs on long-term CBD, particularly in the first few months. The Merck Veterinary Manual specifically notes that chronic CBD use benefits from hepatic profile monitoring.
Visible signs of liver distress in dogs include loss of appetite, vomiting, diarrhea, increased thirst and urination, lethargy, and in more advanced cases, yellowing of the gums, eyes, or inner ears (jaundice). These symptoms aren’t commonly reported with CBD at normal doses, but they warrant immediate veterinary attention if they appear, especially in dogs taking CBD alongside other medications.
Practical Steps for Protecting Your Dog’s Liver
- Baseline blood work: Get a liver panel before starting CBD so you have a reference point for comparison.
- Recheck at 2 to 4 weeks: Early monitoring catches significant enzyme changes before they become a problem.
- Stay within studied doses: Most research supports 2 to 5 mg/kg per day as a range that’s well tolerated in healthy dogs.
- Disclose all medications: NSAIDs, phenobarbital, and other liver-metabolized drugs interact with CBD in measurable ways. Your vet needs the full picture.
- Choose tested products: CBD products vary enormously in actual cannabinoid content and purity. Products with third-party certificates of analysis reduce the risk of unknowingly giving a much higher dose than intended or exposing your dog to contaminants.
For otherwise healthy dogs not on other medications, CBD at reasonable doses appears to cause a predictable, manageable increase in liver enzyme activity without causing structural liver damage. The dogs most at risk are those already on medications that stress the liver, those with pre-existing liver conditions, and those given doses well above studied ranges without monitoring.